SEC Form 4 · accession 0001645627-17-000134
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 27, 2017
Accepted (ET)
Oct 31, 2017 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 27, 2017 | P | 1,000 | $0.0574 | A | 24,023,189 | D | |
| Common Stock | Oct 27, 2017 | P | 1,418 | $0.059 | A | 24,024,607 | D | |
| Common Stock | Oct 27, 2017 | P | 582 | $0.059 | A | 24,025,189 | D | |
| Common Stock | Oct 30, 2017 | P | 3,000 | $0.0598 | A | 24,028,189 | D | |
| Common Stock | Oct 30, 2017 | P | 2,000 | $0.0599 | A | 24,030,189 | D | |
| Common Stock | Oct 30, 2017 | P | 3,000 | $0.065 | A | 24,033,189 | D | |
| Common Stock | Oct 30, 2017 | P | 2,000 | $0.064 | A | 24,035,189 | D |
Table II — derivative securities
No Table II lines on this filing.